Zomedica Corp.
ZOMDF
$0.11
-$0.01-4.97%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.20% | 8.74% | 6.00% | 8.33% | 11.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.20% | 8.74% | 6.00% | 8.33% | 11.33% |
| Cost of Revenue | 15.80% | 6.27% | -2.63% | 4.19% | 7.48% |
| Gross Profit | 7.76% | 9.86% | 10.10% | 10.21% | 13.10% |
| SG&A Expenses | -9.75% | -6.61% | -0.18% | 8.53% | 26.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.18% | -3.40% | 0.74% | 9.75% | 31.70% |
| Operating Income | 17.62% | 12.01% | 3.21% | -10.88% | -50.99% |
| Income Before Tax | -36.63% | -47.84% | -161.67% | -32.56% | -249.26% |
| Income Tax Expenses | -331.71% | 83.45% | 73.71% | 58.12% | 104.33% |
| Earnings from Continuing Operations | -35.90% | -51.99% | -172.43% | -36.06% | -316.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.90% | -51.99% | -172.43% | -36.06% | -316.46% |
| EBIT | 17.62% | 12.01% | 3.21% | -10.88% | -50.99% |
| EBITDA | 23.06% | 17.88% | 9.09% | -6.92% | -54.75% |
| EPS Basic | -35.80% | -51.84% | -171.92% | -35.41% | -314.38% |
| Normalized Basic EPS | 15.98% | 9.22% | -1.06% | -19.05% | -72.44% |
| EPS Diluted | -50.63% | -68.30% | -196.59% | -62.04% | -314.38% |
| Normalized Diluted EPS | 15.98% | 9.22% | -1.06% | -19.05% | -72.44% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |